Renguo Guan

Assessment of the expression of the immune checkpoint molecules PD‐1, CTLA4, TIM‐3 and LAG‐3 across different cancers in relation to treatment response, tumor‐infiltrating immune cells and survival

Lei Tu, Renguo Guan, Hanting Yang et al. · International Journal of Cancer · 2019 · 172 citations · Full text

Life Sciences, Immunology, Oncology +17

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study

Shaohua Li, Jie Mei, Yuan Cheng et al. · Journal of Clinical Oncology · 2022 · 169 citations · Full text

Medicine, Oncology, Pharmacology +15

Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial–mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway

Ye Lin, Zhixiang Jian, Haosheng Jin et al. · Cell Death and Disease · 2020 · 115 citations · Full text

Medicine, Molecular Biology, Oncology +17

Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival

Yan Geng, Renguo Guan, Weifeng Hong et al. · Annals of Translational Medicine · 2020 · 97 citations · Full text

Medicine, Cancer Biology, Oncology +17

The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma

Min Deng, Shiquan Sun, Rongce Zhao et al. · Molecular Medicine · 2022 · 93 citations · Full text

Medicine, Molecular Biology, Oncology +17